1 ML alirocumab 150 MG/ML Auto-Injector

RxCUI: 1659156
RxNorm name: 1 ML alirocumab 150 MG/ML Auto-Injector
Display name: 1 ML alirocumab 150 MG/ML Auto-Injector
Full name: 1 ML alirocumab 150 MG/ML Auto-Injector
Term type: SCD
Status: DailyMed mapping
Updated: 2026-06-04 23:38:56

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
125559	Praluent	alirocumab	351(a)	Rx	2026-08-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Praluent	ALIROCUMAB	Regeneron Pharmaceuticals, Inc.	7bcfbac2-e8ac-4569-8edc-bcde3b1fd172	2026-07-16	Warnings, Adverse reactions	Exact identifier rxcui: 1659156
Praluent	ALIROCUMAB	Sanofi-Aventis U.S. LLC	446f6b5c-0dd4-44ff-9bc2-c2b41f2806b4	2026-07-07	Warnings, Adverse reactions	Exact identifier rxcui: 1659156

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
446f6b5c-0dd4-44ff-9bc2-c2b41f2806b4	alirocumab 150 MG in 1 ML Auto-Injector [PSN] · 1 ML alirocumab 150 MG/ML Auto-Injector [SCD] · alirocumab 150 MG per 1 ML Auto-Injector [SY]	3	33	These highlights do not include all the information needed to use PRALUENT safely and effectively. See full prescribing information for PRALUENT. PRALUENT ® (alirocumab) injection, for subcutaneous use Initial U.S. Approval: 2015	20251023
7bcfbac2-e8ac-4569-8edc-bcde3b1fd172	alirocumab 150 MG in 1 ML Auto-Injector [PSN] · 1 ML alirocumab 150 MG/ML Auto-Injector [SCD] · alirocumab 150 MG per 1 ML Auto-Injector [SY]	3	9	These highlights do not include all the information needed to use PRALUENT safely and effectively. See full prescribing information for PRALUENT. PRALUENT ® (alirocumab) injection, for subcutaneous use Initial U.S. Approval: 2015	20251030